Jean F. Voltaire

Array ( [id] => 7490998 [patent_doc_number] => 08030312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => '5-HT1A receptor subtype agonist' [patent_app_type] => utility [patent_app_number] => 10/876605 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4735 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030312.pdf [firstpage_image] =>[orig_patent_app_number] => 10876605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276479 [patent_doc_number] => 20040235930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Indole derivatives and their use for the treatment of osteoporosis amongst other applications' [patent_app_type] => new [patent_app_number] => 10/875356 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14478 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235930.pdf [firstpage_image] =>[orig_patent_app_number] => 10875356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434990 [patent_doc_number] => 20040266753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Benzo[a]pyrano[3,2-h]acridin-7-one compounds' [patent_app_type] => new [patent_app_number] => 10/872060 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12344 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266753.pdf [firstpage_image] =>[orig_patent_app_number] => 10872060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7027041 [patent_doc_number] => 20050020682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors' [patent_app_type] => utility [patent_app_number] => 10/866141 [patent_app_country] => US [patent_app_date] => 2004-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 32175 [patent_no_of_claims] => 206 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020682.pdf [firstpage_image] =>[orig_patent_app_number] => 10866141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 421959 [patent_doc_number] => 07273890 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-09-25 [patent_title] => 'ST104P, an anti-angiogenic agent' [patent_app_type] => utility [patent_app_number] => 10/865480 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5708 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273890.pdf [firstpage_image] =>[orig_patent_app_number] => 10865480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7319342 [patent_doc_number] => 20040225013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents' [patent_app_type] => new [patent_app_number] => 10/859773 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23251 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20040225013.pdf [firstpage_image] =>[orig_patent_app_number] => 10859773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7372020 [patent_doc_number] => 20040219153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Synergistic tumorcidal response induced by histamine' [patent_app_type] => new [patent_app_number] => 10/859802 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6222 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219153.pdf [firstpage_image] =>[orig_patent_app_number] => 10859802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251161 [patent_doc_number] => 20050272806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Injectable formulations of taxanes for cad treatment' [patent_app_type] => utility [patent_app_number] => 10/858954 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 63174 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272806.pdf [firstpage_image] =>[orig_patent_app_number] => 10858954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255796 [patent_doc_number] => 20050075395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Continuous dosing regimen' [patent_app_type] => utility [patent_app_number] => 10/857235 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6013 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075395.pdf [firstpage_image] =>[orig_patent_app_number] => 10857235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7319006 [patent_doc_number] => 20040224925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs' [patent_app_type] => new [patent_app_number] => 10/856595 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9489 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224925.pdf [firstpage_image] =>[orig_patent_app_number] => 10856595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256114 [patent_doc_number] => 20040259815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Anti-proliferative composition' [patent_app_type] => new [patent_app_number] => 10/496411 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6457 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259815.pdf [firstpage_image] =>[orig_patent_app_number] => 10496411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206146 [patent_doc_number] => 20050043233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/830147 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17893 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043233.pdf [firstpage_image] =>[orig_patent_app_number] => 10830147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061863 [patent_doc_number] => 20050004225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Oxidoreductase inhibitors and methods of screening and using thereof' [patent_app_type] => utility [patent_app_number] => 10/826679 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 17953 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004225.pdf [firstpage_image] =>[orig_patent_app_number] => 10826679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6965994 [patent_doc_number] => 20050232891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Methods of treating skin with diphosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 10/825703 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6691 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232891.pdf [firstpage_image] =>[orig_patent_app_number] => 10825703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346871 [patent_doc_number] => 20040192654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Methods of treating leukemia' [patent_app_type] => new [patent_app_number] => 10/824563 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5037 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192654.pdf [firstpage_image] =>[orig_patent_app_number] => 10824563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276334 [patent_doc_number] => 20040235785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Potentiator of antitumoral agents in the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/488682 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2848 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235785.pdf [firstpage_image] =>[orig_patent_app_number] => 10488682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329829 [patent_doc_number] => 20040254123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Malignant cell differentiation inducer compositions and utilization of the same' [patent_app_type] => new [patent_app_number] => 10/491790 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4439 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254123.pdf [firstpage_image] =>[orig_patent_app_number] => 10491790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672824 [patent_doc_number] => 20040180955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy' [patent_app_type] => new [patent_app_number] => 10/807620 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12238 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180955.pdf [firstpage_image] =>[orig_patent_app_number] => 10807620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672848 [patent_doc_number] => 20040180931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods for treating Parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 10/806409 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5467 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180931.pdf [firstpage_image] =>[orig_patent_app_number] => 10806409 [rel_patent_id] =>[rel_patent_doc_number] =>)